Korean Drug Co., Ltd.

A014570

KR7014570006

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 03:30:00 05/07/2024 am IST			5-day change	1st Jan Change
5,460 ^KRW	+0.37%		-1.62%	-23.96%

2023	Korean Drug Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2021	Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 14, 2020.	CI

Tranche Update on Korean Drug Co. Ltd.'s Equity Buyback Plan announced on September 3, 2013.

December 02, 2013

From September 3, 2013 to November 26, 2013, the company has repurchased 53,000 shares, representing 0.47% for KRW 170.43 million. With this, the company has completed the repurchase of 53,000 shares, representing 0.47% for KRW 170.43 million under the buyback announced on September 3, 2013.

Latest news about Korean Drug Co., Ltd.

Korean Drug Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 14, 2020.	02/21/02	CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 14, 2020.	02/21/02	CI
Korean Drug Co., Ltd.'s Equity Buyback announced on December 14, 2020, has closed with 14,000 shares, representing 0.13% for KRW 143.66 million.	26/21/26	CI
Korean Drug Co., Ltd. announces an Equity Buyback for 14,000 shares.	14/20/14	CI
Korean Drug Co., Ltd. authorizes a Buyback Plan.	14/20/14	CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 11, 2018.	11/19/11	CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 11, 2018.	11/19/11	CI
Korean Drug Co., Ltd.’s Equity Buyback announced on December 11, 2018 has closed with 20,000 shares, for KRW 152.32 million.	06/19/06	CI
Korean Drug Co., Ltd. announces an Equity Buyback for 20,000 shares.	11/18/11	CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.	11/18/11	CI
Tranche Update on Korean Drug Co. Ltd.'s Equity Buyback Plan announced on March 8, 2016.	07/16/07	CI
Korean Drug Co. Ltd.'s Equity Buyback announced on March 8, 2016 has closed with 15,000 shares, representing 0.14% for KRW 104.64 million.	02/16/02	CI
Korean Drug Co. Ltd. announces an Equity Buyback for 15,000 shares.	08/16/08	CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.	08/16/08	CI
Tranche Update on Korean Drug Co. Ltd.'s Equity Buyback Plan announced on November 10, 2014.	09/15/09	CI
Korean Drug Co. Ltd.'s Equity Buyback announced on November 10, 2014 has closed with 20,000 shares, representing 0.18% for KRW 82.6 million.	02/15/02	CI
Korea Securities Finance Corporation acquired 3.64% stake in Korean Drug Co. Ltd..	09/15/09	CI
Korean Drug Co. Ltd. announces an Equity Buyback for 20,000 shares.	10/14/10	CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.	10/14/10	CI
Korea Securities Finance Corporation, Investment Arm acquired a 4.2% stake in Korean Drug Co. Ltd..	11/14/11	CI
Tranche Update on Korean Drug Co. Ltd.'s Equity Buyback Plan announced on September 3, 2013.	02/13/02	CI
Korean Drug Co. Ltd.’s Equity Buyback announced on September 3, 2013 has closed with 53,000 shares, representing 0.47% for KRW 170.43 million.	26/13/26	CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.	03/13/03	CI
Korean Drug Co. Ltd. announces an Equity Buyback for 53,000 shares.	03/13/03	CI

Chart Korean Drug Co., Ltd.

Duration

Period

More charts

Company Profile

KOREAN DRUG CO.,LTD is a Korea-based company engaged in the manufacture and distribution of pharmaceuticals. The Companyâs products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food, including multi-symptom cold medicines, blood-forming nutrients, treatments for central nervous system, remedies for respiratory diseases, dermatological agents, vitamins, antifungal agents, antipyretics, analgesics, anti-inflammatory drugs, antibiotics, allergic treatments, calcium and vitamin D tablets and home pregnancy test kits, among others.

Sector

Pharmaceuticals

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
KOREAN DRUG CO., LTD.	-23.96%	43.18M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+24.53%	45.07B
OTSUKA HOLDINGS CO., LTD.	+30.99%	23.39B
SANDOZ GROUP AG	+24.13%	16.08B
CIPLA LIMITED	+21.15%	14.6B
ZYDUS LIFESCIENCES LIMITED	+68.67%	14.01B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-13.29%	6.38B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.53%	5.64B